Vishnumurthy Kodumuru

This inventor holds 28 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 16 EPO patents, primarily in Heterocyclic Compounds. Top assignees: Xenon Pharmaceuticals Inc., Novartis Ag. Active years: 2008-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vishnumurthy Kodumuru. Retrieved from https://idiyas.com/inventor/vishnumurthy-kodumuru

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 3)

CIPO Patents = 2

EPO Patents = 16 (Patent Applications = 12)

Average Co-Inventor Count = 9.1

ph-index = 10

Forward Citations = 210(Granted Patents)

Location History:

Burnaby, CA (US) (2011)
Waltham, MA (US) (2012)
Burnaby, CA (2008 - 2015)

Company Filing History:

25 out of 110

Xenon Pharmaceuticals Inc.

where one patent can have more than one assignee

Years Active: 2008-2015

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

Stearoyl-CoA Desaturase

Pyridazine Derivatives

Aminothiazole Derivatives

Therapeutic Agents

Combination Therapy

Inhibitors

Piperazine Derivatives

Bicyclic Derivatives

Organic Compounds

Pyridyl Derivatives

Thiazole Derivatives

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9187426 - Organic compounds (2015-11-17),

2. 8541457 - Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors (2013-09-24),

3. 8501746 - Organic compounds (2013-08-06),

4. 8383628 - Pyridyl derivatives and their use as therapeutic agents (2013-02-26),

5. 8318949 - Organic compounds (2012-11-27),

6. 8293768 - Organic compounds (2012-10-23),

7. 8258160 - SCD1 inhibitors triazole and tetrazole compounds (2012-09-04),

8. 8153636 - Pyridyl derivatives and their use as therapeutic agents (2012-04-10),

9. 8148378 - Pyridazine derivatives and their use as inhibitors of stearoyl-CoA desaturase-1 activity in a mammal (2012-04-03),

10. 8071603 - Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors (2011-12-06),

11. 8063084 - Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levels (2011-11-22),

12. 8049016 - Thiazole derivatives which inhibit stearoyl-CoA desaturase enzymes (2011-11-01),

13. 8030488 - Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents (2011-10-04),

14. 8026360 - Substituted pyridazines as stearoyl-CoA desaturase inhibitors (2011-09-27),

15. 7951805 - Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase (2011-05-31),

Title: Vishnumurthy Kodumuru: Innovator in Organic Chemistry

Introduction

Vishnumurthy Kodumuru is a prominent inventor based in Burnaby, Canada, recognized for his significant contributions to organic chemistry. With an impressive portfolio of 28 patents, his work focuses on creating innovative solutions for health-related issues through the development of new organic compounds.

Latest Patents

Among his latest innovative endeavors, Vishnumurthy has patented several organic compounds designed to modulate the activity of stearoyl-CoA desaturase. His research presents heterocyclic derivatives that can effectively influence this enzyme's activity. Additionally, he has developed aminothiazole derivatives aimed at inhibiting human stearoyl-CoA desaturase, providing methods for treating diseases associated with this enzyme in mammals, particularly humans. Pharmaceutical compositions incorporating these compounds are also part of his patented inventions, showcasing his commitment to advancing healthcare.

Career Highlights

Vishnumurthy has made a mark in the pharmaceutical industry through his roles at Xenon Pharmaceuticals Inc. and Novartis AG. His experience in these esteemed companies has enabled him to hone his expertise and drive meaningful innovations in the field of drug development.

Collaborations

Throughout his career, Vishnumurthy has collaborated with notable colleagues such as Rajender Kamboj and Shaoyi Sun. These partnerships have likely contributed to the success of his research and the advancement of his patented technologies.

Conclusion

In summary, Vishnumurthy Kodumuru stands as a key figure in the realm of organic chemistry and pharmaceutical innovation. His numerous patents reflect a deep commitment to research that can positively impact health and wellness. As he continues to develop groundbreaking solutions, his contributions will undoubtedly shape the future of medical science.

Profile summary based on public USPTO records.